Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS)Christine M. Oshansky, Rick A. Bright, Corrina Pavetto et al.|Vaccine|2018Cited by 29
Clinical Development of Therapeutic Agents for Hospitalized Patients With Influenza: Challenges and InnovationsJames C. King, Rick A. Bright, Michael G. Ison et al.|Open Forum Infectious Diseases|2019Cited by 16
Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adultsChristine M. Oshansky, Rubén O. Donis, James C. King et al.|npj Vaccines|2021Cited by 10